ANIKA THERAPEUTICS INC (ANIK) Stock Income Statement
NASDAQ:ANIK - Nasdaq - US0352551081 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 119.91M | 120.79M | 156.20M | 147.80M | 130.50M | |||
| Cost Of Goods | 43.30M | 38.26M | 62.70M | 64.90M | 61.40M | |||
| Gross Profit | 76.60M | 82.53M | 93.60M | 82.90M | 69.00M | |||
| Operating Expenses | 78.91M | 78.66M | 112.90M | 80.30M | 54.90M | |||
| Research and Development | 25.54M | 21.76M | 28.20M | 27.30M | 23.40M | |||
| Selling, General, and Administrative Expenses | 53.37M | 56.89M | 84.80M | 74.10M | 60.10M | |||
| Operating Income | -2.31M | 3.88M | -19.40M | 2.60M | 14.20M | |||
| Interest Income/Expense | 2.34M | 2.31M | 700.00K | -200.00K | -300.00K | |||
| Non Recurring Items | -2.79M | -3.03M | 0.00 | 0.00 | -42.50M | |||
| Income Before Taxes | -2.76M | 3.16M | -18.70M | 2.40M | -28.60M | |||
| Income Tax | 6.06M | 6.59M | -3.90M | -1.70M | -4.60M | |||
| Net Income | -56.38M | -82.67M | -14.90M | 4.10M | -24.00M | |||
| EBITDA | 5.81M | 18.09M | -4.92M | 16.92M | 27.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.83 | -5.64 | -1.02 | 0.28 | -1.69 | |||
| Non GAAP EPS | -2.07 | -5.41 | -0.89 | 0.29 | -0.64 | |||
| Statistics | ||||||||
| Gross Profit Margin | 63.89% | 68.33% | 59.92% | 56.09% | 52.87% | |||
| Profit Margin | -47.02% | -68.44% | -9.54% | 2.77% | -18.39% | |||
| Operating Profit Margin | -1.93% | 3.21% | -12.42% | 1.76% | 10.88% | |||
All data in USD